Concepedia

Wende Niforatos

WN

23

Publications

2.7K

Citations

20

H-Index

1999

Active since

Affiliations

Abbott Fund(Current)

Abbott (United Kingdom)

Abbott (United States)

AbbVie (United States)

GTx (United States)

Wende Niforatos is an author at Abbott Fund specializing in medicine, pharmacology, and physiology.

Top concepts

Publications per year

1999–2014

23

Publications

23

A-317491, a novel potent and selective non-nucleotide antagonist of P2X <sub>3</sub> and P2X <sub>2/3</sub> receptors, reduces chronic inflammatory and neuropathic pain in the rat

Michael F. Jarvis, Edward C. Burgard, Steve McGaraughty et al. · Proceedings of the National Academy of Sciences · 2002 · 458 citations · Full text

Pharmacological characterization of recombinant human and rat P2X receptor subtypes

Bruce R. Bianchi, Kevin J. Lynch, Edward Touma et al. · European Journal of Pharmacology · 1999 · 336 citations

, , +6

TRPV1 Receptors in the CNS Play a Key Role in Broad-Spectrum Analgesia of TRPV1 Antagonists

Minghua Cui, Prisca Honoré, Chengmin Zhong et al. · Journal of Neuroscience · 2006 · 310 citations · Full text

, , +17

Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation

Jun Chen, Shailen K. Joshi, Stanley DiDomenico et al. · Pain · 2011 · 269 citations · Full text

Structure−Activity Relationship Studies on a Series of Novel, Substituted 1-Benzyl-5-phenyltetrazole P2X<sub>7</sub>Antagonists

Derek W. Nelson, Robert J. Gregg, Michael E. Kort et al. · Journal of Medicinal Chemistry · 2006 · 227 citations · Full text

, , +20

Rows per page

1–5 of 23